The athletic apparel maker's board of directors boosted its stock buyback plan by
The biopharmaceutical company signed a co-development deal with Bharat Biotech for the COVID-19 vaccine Covaxin.
European regulators approved a booster shot of the drug developer's COVID-19 vaccine for severely immunocompromised individuals.
The communications company reported weak fiscal fourth-quarter revenue.
Gold prices edged lower and weighed on the gold producer.
Banks gained ground as bond yields rose, which helps them charge more lucrative interest on loans.
Energy prices continued rising and helped send energy stocks higher.
A report showed that the
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source